Conference Call with Dixon Technologies (India) Management and Analysts on Q4FY25 & Full Year Performance and Outlook. Listen to the full earnings transcript.
Healthcare Facilities company Max Healthcare Institute announced Q4FY25 & FY25 results Q4FY25 Financial Highlights: Network gross revenue was Rs 2,429 crore, reflecting a growth of +29% YoY and +2% QoQ. YoY growth was driven by increase in OBDs. Network Operating EBITDA was Rs 632 crore, reflecting a growth of 26% YoY & 2% QoQ. EBITDA Margin for the Network stood at 27.2% compared to 28.0% in Q4FY24 and 27.3% in Q3FY25. Overall EBITDA per bed was Rs 73.9 lakhs compared to Rs 76.0 lakhs in Q4FY24 and Rs 73.0 lakhs in Q3FY25. Profit after tax (PAT) for the quarter stood at Rs 376 crore compared to Rs 311 crore in Q4FY24, and Rs 372 crore in Q3FY25. Free cash from operations was Rs 422 crore versus Rs 412 crore in Q4FY24 and Rs 303 crore in Q3FY25. FY25 Financial Highlights: For the year ended Mar’25, the Network gross revenue stood at Rs 9,065 crore representing a growth of 26% over the corresponding period last fiscal, mainly driven by increase in OBDs. The Network Operating EBITDA grew by 22% over the year ended Mar’24, and stood at Rs 2,319 crore. The operating margin for year ended Mar’25 was 26.8%, including New Units vs 27.8% in last year. PAT before Exceptional Items for year ended Mar’251 stood at Rs 1,392 crore vs Rs 1,278 crore in year ended Mar’24, registering a growth of 9%. Cash from operations for the Network during year ended Mar’25 was Rs 1,447 crore. Net Debt at the end of year ended Mar’25 stood at Rs 1,576 crore. Commenting on Q4 results, Abhay Soi, Chairman and Managing Director, Max Healthcare Institute said: “We are proud to report the 18th consecutive quarter of year-on-year growth in both Revenue and Operating EBITDA — a testament to the strength of our operating model, the trust of our patients, and the relentless efforts of our teams. We also took significant strategic steps in Q4 to position the Company for long-term growth, including corporate actions and two M&A; transactions. Notably, we completed the acquisition of land adjoining MSSH, Vaishali, paving the way for a brownfield expansion in this very busy hospital. As we look ahead, we are excited about commencing the operations at our 3 new brownfield towers in Saket, Nanavati and Mohali hospitals in the next 3 months and adding 1,500 beds to the capacity in the current financial year, which will further reinforce our leadership in quality healthcare delivery across geographies that we operate in.” Result PDF